Healthcare provider profile · identity verified

Kathy Bolus, MD

Internal Medicine · CHARLESTON, SC · NPI 1114995669

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	525	147
Rosuvastatin Calcium	Rosuvastatin Calcium	477	145
Atorvastatin Calcium	Atorvastatin Calcium	448	132
Levothyroxine Sodium	Levothyroxine Sodium	389	103
Lisinopril	Lisinopril	287	83
Simvastatin	Simvastatin	263	72
Zolpidem Tartrate	Zolpidem Tartrate	263	50
Omeprazole	Omeprazole	243	76
Fluticasone Propionate	Fluticasone Propionate	211	108
Benazepril Hcl	Benazepril Hcl	175	50
Metoprolol Succinate	Metoprolol Succinate	169	50
Bupropion Xl	Bupropion Hcl	160	48
Hydrochlorothiazide	Hydrochlorothiazide	149	42
Gabapentin	Gabapentin	143	48
Alendronate Sodium	Alendronate Sodium	142	43
Eliquis	Apixaban	127	33
Olmesartan Medoxomil	Olmesartan Medoxomil	124	41
Sertraline Hcl	Sertraline Hcl	123	35
Ozempic	Semaglutide	114	22
Escitalopram Oxalate	Escitalopram Oxalate	106	33
Lorazepam	Lorazepam	100	31
Fluoxetine Hcl	Fluoxetine Hcl	94	29
Pantoprazole Sodium	Pantoprazole Sodium	94	29
Tramadol Hcl	Tramadol Hcl	88	21
Potassium Chloride	Potassium Chloride	85	26
Metformin Hcl Er	Metformin Hcl	82	26
Alprazolam	Alprazolam	76	21
Duloxetine Hcl	Duloxetine Hcl	75	20
Losartan Potassium	Losartan Potassium	75	22
Montelukast Sodium	Montelukast Sodium	74	25
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	72	17
Estradiol	Estradiol	70	34
Pravastatin Sodium	Pravastatin Sodium	70	22
Spironolactone	Spironolactone	68	19
Chlorthalidone	Chlorthalidone	66	18
Famotidine	Famotidine	66	21
Tamsulosin Hcl	Tamsulosin Hcl	64	22
Albuterol Sulfate Hfa	Albuterol Sulfate	62	35
Allopurinol	Allopurinol	62	18
Metformin Hcl	Metformin Hcl	61	21
Celecoxib	Celecoxib	56	21
Venlafaxine Hcl Er	Venlafaxine Hcl	56	13
Paroxetine Hcl	Paroxetine Hcl	55	18
Valsartan	Valsartan	55	15
Metoprolol Tartrate	Metoprolol Tartrate	54	17
Furosemide	Furosemide	52	16
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	51	14
Citalopram Hbr	Citalopram Hydrobromide	51	14
Mirtazapine	Mirtazapine	51	17
Esomeprazole Magnesium	Esomeprazole Magnesium	49	16
Clonazepam	Clonazepam	47	suppressed
Methylprednisolone	Methylprednisolone	47	31
Meloxicam	Meloxicam	46	17
Trulicity	Dulaglutide	45	suppressed
Ezetimibe	Ezetimibe	44	15
Amitriptyline Hcl	Amitriptyline Hcl	42	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	42	suppressed
Trazodone Hcl	Trazodone Hcl	41	12
Jardiance	Empagliflozin	39	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	39	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	39	suppressed
Donepezil Hcl	Donepezil Hcl	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	14
Temazepam	Temazepam	37	suppressed
Diazepam	Diazepam	36	12
Finasteride	Finasteride	34	11
Synthroid	Levothyroxine Sodium	34	11
Atenolol	Atenolol	33	suppressed
Irbesartan	Irbesartan	33	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	32	suppressed
Carvedilol	Carvedilol	32	suppressed
Memantine Hcl	Memantine Hcl	31	suppressed
Methimazole	Methimazole	31	suppressed
Ondansetron Odt	Ondansetron	31	suppressed
Glimepiride	Glimepiride	30	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	30	11
Clopidogrel	Clopidogrel Bisulfate	29	suppressed
Mounjaro	Tirzepatide	29	suppressed
Prednisone	Prednisone	29	suppressed
Ramipril	Ramipril	28	suppressed
Solifenacin Succinate	Solifenacin Succinate	28	12
Valacyclovir	Valacyclovir Hcl	28	15
Wixela Inhub	Fluticasone Propion/Salmeterol	27	suppressed
Ibandronate Sodium	Ibandronate Sodium	25	suppressed
Mometasone Furoate	Mometasone Furoate	25	suppressed
Baclofen	Baclofen	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	22	suppressed
Ipratropium Bromide	Ipratropium Bromide	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Colchicine	Colchicine	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	20	suppressed
Oxycontin	Oxycodone Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	16
Telmisartan	Telmisartan	19	suppressed
Glipizide	Glipizide	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	17	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Pregabalin	Pregabalin	17	suppressed
Clonidine	Clonidine	16	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	16	suppressed
Divalproex Sodium	Divalproex Sodium	16	suppressed
Rizatriptan	Rizatriptan Benzoate	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Ezetimibe-Simvastatin	Ezetimibe/Simvastatin	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Nystatin	Nystatin	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	suppressed
Amoxicillin	Amoxicillin	12	11
Myrbetriq	Mirabegron	12	suppressed
Raloxifene Hcl	Raloxifene Hcl	12	suppressed
Repatha Sureclick	Evolocumab	12	suppressed
Humalog Kwikpen U-200	Insulin Lispro	11	suppressed
Linzess	Linaclotide	11	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error